A new study reveals that women with obesity experience a higher prevalence of menopausal symptoms and lower efficacy of hormone treatment (HT). Obesity is a major public health issue around the world. Health officials and specialists have urged people to live a healthy lifestyle, and advised them to get some exercise and consume nutritious foods so that they can keep their weight under control.
According to the World Health Organisation (WHO), around 650 million individuals are obese. According to a recent study, obesity may worsen a woman’s menopausal symptoms and reduce the amount of relief she receives from hormone therapy.
Hormone therapy remains the most effective treatment for a wide range of menopausal symptoms. A new five-year research of 119 patients investigated the relationship between obesity and self-reported efficacy of hormone treatment in peri and postmenopausal women. Obesity was defined in this study as having a BMI (body mass index) more than or equal to 30.
There were no statistically significant differences in age, duration of menopause, or usage of HT between the two groups of patients (obesity and non-obese). Obese women, on the other hand, were more likely to experience hot flashes, genitourinary problems, mood swings, and lower libido. Based on the findings, the researchers concluded that menopausal women who were obese had an increase in menopause symptom prevalence and reduced HT efficacy.